Cipla
Anand Bhaltilak is an experienced professional in injectable formulation development, currently serving as Assistant Manager at Cipla since October 2021, focusing on formulation development for regulated markets. Prior to this role, Anand worked as a Research Associate at Intas Pharmaceuticals from May 2020 to October 2021, contributing to the formulation development department for injectables. Anand began a career in formulation as a Research Associate at NEON LABORATORIES LIMITED from March 2018 to April 2020, specializing in the development of injectable drug products for domestic and ROW markets. Anand holds a Bachelor of Pharmacy degree from Government College of Pharmacy Aurangabad, completed between 2015 and 2017, and previously studied at Maulana Azad Educational Trust's Y.B. Chavan College of Pharmacy from 2012 to 2015.
This person is not in any teams
This person is not in any offices
Cipla
17 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.